Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.

Autor: Swaminath A; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Parpia S; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Wierzbicki M; Juravinski Cancer Centre, Department of Medical Physics, McMaster University, Hamilton, Ontario, Canada., Kundapur V; Saskatchewan Cancer Agency, Department of Radiation Oncology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Faria S; Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada., Okawara GS; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Tsakiridis TK; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Ahmed N; Section of Radiation Oncology, Department of Radiology, Rady Faculty of Health Sciences, University of Manitoba and CancerCare Manitoba Research Institute, Winnipeg, Manitoba, Canada., Bujold A; Département de Radio-oncologie Clinique-Enseignement-Recherche, Centre intégré universitaire de soins et services sociaux de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada., Hirmiz K; Department of Radiation Oncology, Windsor Regional Cancer Centre, Windsor, Ontario, Canada., Owen T; Department of Oncology, Queen's University, Cancer Centre of Southeast Ontario at Kingston Health Sciences Centre, Kingston, Ontario, Canada., Leong N; Allan Blair Cancer Centre, Department of Radiation Oncology, University of Saskatchewan, Regina, Saskatchewan, Canada., Ramchandar K; Department of Oncology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada., Filion E; Radiation Oncology Department, Centre Hospitalier de l'Université de Montréal, Notre Dame Hospital, Montreal, Quebec, Canada., Lau H; Department of Oncology, University of Calgary, Calgary, Alberta, Canada., Gabos Z; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada., Thompson R; Department of Radiation Oncology, Dalhousie University, Saint John, New Brunswick, Canada., Yaremko B; Department of Radiation Oncology, Western University, London, Ontario, Canada., Mehiri S; Département de Radio-oncologie, CISSS Montérégie, Hôpital Charles Lemoyne, Montreal, Quebec, Canada., Louie AV; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Quan K; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Levine MN; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Wright JR; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Whelan TJ; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Nov; Vol. 10 (11), pp. 1571-1575. Date of Electronic Publication: 2024 Sep 19.

Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.

Autor: Swaminath A; Juravinski Cancer Centre, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Wierzbicki M; Juravinski Cancer Centre, McMaster University, Department of Medical Physics, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Parpia S; Ontario Clinical Oncology Group, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Kundapur V; Saskatchewan Cancer Agency, University of Saskatchewan, Department of Radiation Oncology, 20 Campus Drive, Saskatoon, SK S7N 4H4, Canada., Faria S; Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada., Ahmed N; Department of Radiology, Section of Radiation Oncology, Rady Faculty of Health Sciences, University of Manitoba and CancerCare Manitoba Research Institute, Winnipeg, Manitoba, Canada., Bujold A; Département de Radio-oncologie Clinique-Enseignement-Recherche, Centre intégré universitaire de soins et services sociaux de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada., Hirmiz K; Department of Radiation Oncology, Windsor Regional Cancer Centre, Windsor, Ontario, Canada., Owen T; Department of Oncology, Queen's University, Cancer Centre of Southeast Ontario at Kingston Health Sciences Centre, Kingston, Ontario, Canada., Leong N; Allan Blair Cancer Centre, Department of Radiation Oncology, University of Saskatchewan, Regina, Saskatchewan, Canada., Ramchandar K; Department of Oncology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada., Filion E; Radiation Oncology Department, Centre Hospitalier de l'Université de Montréal, Notre Dame Hospital, Montréal, Quebec, Canada., Lau H; Department of Oncology, University of Calgary, Calgary, Alberta, Canada., Thompson R; Department of Radiation Oncology, Dalhousie University, Saint John, New Brunswick, Canada., Yaremko B; Department of Radiation Oncology, Western University, London, Ontario, Canada., Gabos Z; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada., Mehiri S; Département de Radio-oncologie, CISSS Montérégie, Hôpital Charles Lemoyne, Montréal, Quebec, Canada., Wright JR; Juravinski Cancer Centre, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Tsakiridis TK; Juravinski Cancer Centre, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Cline K; Ontario Clinical Oncology Group, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Whelan TJ; Juravinski Cancer Centre, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2022 Oct 13; Vol. 37, pp. 145-152. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).

Effect of negative expiratory pressure (NEP) on respiratory system flow resistance in awake snorers and non-snorers

Autor: Tantucci, Claudio, Duguet, A, Ferretti, A, Mehiri, S, Similowski, T, Arnulf, I, Zelter, M, DERENNE J., Ph, MILIC EMILI, J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::319cb464a5f1400403b30986b85bc628
http://hdl.handle.net/11379/8834

Post-pneumonectomy pulmonary edema: analysis and risk factors

Autor: François Parquin, Marchal M, Mehiri S, Hervé P, B Lescot

Publikováno v: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 10(11)

Objective. To analyze the risk factors for postpneumonectomy pulmonary edema in 146 consecutive patients. Methods. In 1992, 146 consecutive patients, aged 60.5±9.4 years, under― went pneumonectomy, mostly for cancer (n=136). Pulmonary edema was de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6897c6ceb7431f25dea4aa071a79053
https://pubmed.ncbi.nlm.nih.gov/8971502

RCMI préopératoire des sarcomes rétropéritonéaux : où en sommes nous ?

Autor: Mehiri, S., El-Bared, N., Taussky, D., Patocskai, E., Roberge, D., Donath, D.

Publikováno v: In Cancer / Radiothérapie October 2013 17(5-6):576-577